Literature DB >> 19633272

The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion.

Paul Stroemer1, Sara Patel, Andrew Hope, Cathy Oliveira, Kenny Pollock, John Sinden.   

Abstract

BACKGROUND: This study investigated behavioral recovery in rats following implanting increasing doses of CTX0E03 cells into the putamen ipsilateral to the stroke damage. Postmortem histological analysis investigated possible mechanisms of behavioral recovery.
METHODS: . At 4 weeks after middle cerebral artery occlusion (MCAO), rats were treated with 4500, 45,000, or 450,000 CTX0E03 cells or vehicle implanted into the putamen with testing on a battery of tasks preocclusion and postocclusion. Histological examination of brains included assessment of lesion volumes, implant cell survival and differentiation, changes to host brain matrix, angiogenesis, and neurogenesis using immunohistochemical methods.
RESULTS: . Statistically significant dose-related recovery in sensorimotor function deficits (bilateral asymmetry test [BAT; P < .0002] in the mid- and high-dose groups and rotameter test after amphetamine exposure [P < .05] in the high-dose group) was found in the CTX0E03 cell implanted groups compared to the vehicle group. In-life functional improvements correlated with cell dose, though did not correlate with survival of CTX0E03 cells measured at postmortem. Surviving CTX0E03 cells differentiated into oligodendroglial and endothelial phenotypes. MCAO-induced reduction of neurogenesis in the subventricular zone (SVZ) was partially restored to that observed in sham operated controls. No adverse CTX0E03 cell-related effects were observed during in-life observations or on tissue histology.
CONCLUSIONS: . This study found that the implantation of CTX0E03 human neural stem cells in rats after MCAO stroke promoted significant behavioral recovery depending on cell dose. The authors propose a paracrine trophic mechanism, which is triggered early after CTX0E03 cell implantation, and which in turn targets restoration of neurogenesis in the SVZ of MCAO rats.

Entities:  

Mesh:

Year:  2009        PMID: 19633272     DOI: 10.1177/1545968309335978

Source DB:  PubMed          Journal:  Neurorehabil Neural Repair        ISSN: 1545-9683            Impact factor:   3.919


  68 in total

1.  Differential pathotropism of non-immortalized and immortalized human neural stem cell lines in a focal demyelination model.

Authors:  Daniela Ferrari; Cristina Zalfa; Laura Rota Nodari; Maurizio Gelati; Luigi Carlessi; Domenico Delia; Angelo Luigi Vescovi; Lidia De Filippis
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

2.  MRI stem cell tracking for therapy in experimental cerebral ischemia.

Authors:  Pedro Ramos-Cabrer; Mathias Hoehn
Journal:  Transl Stroke Res       Date:  2011-10-27       Impact factor: 6.829

3.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

4.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

5.  Preliminary Reports of Stereotaxic Stem Cell Transplants in Chronic Stroke Patients.

Authors:  Cesar V Borlongan
Journal:  Mol Ther       Date:  2016-10       Impact factor: 11.454

Review 6.  Novel Stroke Therapeutics: Unraveling Stroke Pathophysiology and Its Impact on Clinical Treatments.

Authors:  Paul M George; Gary K Steinberg
Journal:  Neuron       Date:  2015-07-15       Impact factor: 17.173

7.  Host induction by transplanted neural stem cells in the spinal cord: further evidence for an adult spinal cord neurogenic niche.

Authors:  Leyan Xu; Vasiliki Mahairaki; Vassilis E Koliatsos
Journal:  Regen Med       Date:  2012-11       Impact factor: 3.806

8.  Characterization of gene expression changes in human neural stem cells and endothelial cells modeling a neurovascular microenvironment.

Authors:  Chung-Hsing Chou; Michel Modo
Journal:  Brain Res Bull       Date:  2020-02-21       Impact factor: 4.077

9.  Stem cell mediation of functional recovery after stroke in the rat.

Authors:  Pedro Ramos-Cabrer; Carles Justicia; Dirk Wiedermann; Mathias Hoehn
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

10.  c-MycERTAM transgene silencing in a genetically modified human neural stem cell line implanted into MCAo rodent brain.

Authors:  Lara Stevanato; Randolph L Corteling; Paul Stroemer; Andrew Hope; Julie Heward; Erik A Miljan; John D Sinden
Journal:  BMC Neurosci       Date:  2009-07-21       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.